Advancing women’s health: innovative applications of sacral neuromodulation in pelvic floor dysfunctions
Archives of Gynecology and Obstetrics · 16.09.2025 · 312 (5) · 1489-1501
DOI: 10.1007/s00404-025-08182-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 16.09.2025. Verfasst von Jing Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Second Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, 650500, Yunnan, China. Hauptthemen laut MEDLINE: Pelvic Floor Disorders, Electric Stimulation Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Yunnan Province Major Biomedical Research Project, Yunnan Province Xingdian Talent Support Program.
Abstract (Originalsprache)
Female pelvic floor dysfunctions (PFDs), a global health issue, encompass a range of lower urinary tract and bowel dysfunctions, including urinary incontinence, urinary retention, fecal incontinence, constipation, pelvic pain, and sexual dysfunction. PFDs exhibit high prevalence rates and prolonged recovery periods, resulting in significant economic burdens for patients and healthcare systems. Recently, sacral neuromodulation (SNM) has emerged as a minimally invasive, safe, and effective neuromodulatory intervention, representing a significant advance in the management of refractory PFDs. This technology modulates the sacral nerve reflex pathways through an implanted electrode, enabling simultaneous improvement of multiple PFD symptoms. It is specifically indicated for conditions including overactive bladder, non-obstructive urinary retention, and fecal incontinence, with potential therapeutic benefits extending to chronic pelvic pain, sexual dysfunction, and neurogenic bladder. This paper systematically reviews the underlying mechanisms and technological advancements of SNM, providing a comprehensive analysis of its established applications (overactive bladder, non-obstructive urinary retention, fecal incontinence) and examining emerging uses in other PFD domains. Furthermore, incorporating technological innovations and long-term follow-up data, this paper explores the optimization of indications, safety protocols, and future research avenues for SNM, offering a comprehensive outlook on clinical practice and prospective developments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Second Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, 650500, Yunnan, China.
- Department of Emergency Trauma Surgery, The First People's Hospital of Yunnan Province, Kunming, 650032, Yunnan, China. khyy_ll@163.com.
- Department of Rehabilitation Medicine, The First People's Hospital of Yunnan Province, Kunming, 650032, Yunnan, China. 15825255288@139.com.
Förderung
- National Natural Science Foundation of China
- Yunnan Province Major Biomedical Research Project
- Yunnan Province Xingdian Talent Support Program
Zitieren
APA
Fu, J., Li, Z., Pu, J., Liu, Y., Mao, Q., Li, C., Li, L., & Gai, X. (2025). Advancing women’s health: innovative applications of sacral neuromodulation in pelvic floor dysfunctions. Archives of Gynecology and Obstetrics, 312(5), 1489-1501. https://doi.org/10.1007/s00404-025-08182-5
Vancouver
Fu J, Li Z, Pu J, Liu Y, Mao Q, Li C, et al. Advancing women’s health: innovative applications of sacral neuromodulation in pelvic floor dysfunctions. Archives of Gynecology and Obstetrics. 2025;312(5):1489-1501. doi:10.1007/s00404-025-08182-5
BibTeX
@article{Fu2025,
author = {Fu, Jing and Li, Zhong and Pu, Jianlin and Liu, YaDong and Mao, Qiuyue and Li, Chunlan and Li, Li and Gai, Xuesong},
title = {Advancing women’s health: innovative applications of sacral neuromodulation in pelvic floor dysfunctions},
journal = {Archives of Gynecology and Obstetrics},
year = {2025},
volume = {312},
number = {5},
pages = {1489--1501},
doi = {10.1007/s00404-025-08182-5}
}
EUVIMED